|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Claritin-D_12_Hour
gptkb:Claritin_Liquid
gptkb:Bayer_Allergy_Relief
gptkb:Claritin-D
gptkb:Claritin_Kids
|
|
gptkbp:approves
|
gptkb:1993
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Claritin
gptkb:Alavert
|
|
gptkbp:category
|
B
|
|
gptkbp:class
|
piperidine derivative
|
|
gptkbp:contraindication
|
hypersensitivity to loratadine
|
|
gptkbp:discovered_by
|
gptkb:Schering-Plough_Corporation
|
|
gptkbp:duration
|
24 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:formulation
|
gptkb:product
tablets
orally disintegrating tablets
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Loratadine
|
|
gptkbp:ingredients
|
C22 H23 Cl N2 O2
|
|
gptkbp:interacts_with
|
gptkb:beer
CY P2 D6 inhibitors
CY P3 A4 inhibitors
|
|
gptkbp:is_atype_of
|
R06 A X13
|
|
gptkbp:is_available_on
|
generic
|
|
gptkbp:is_used_for
|
allergic rhinitis
chronic urticaria
|
|
gptkbp:lifespan
|
8 to 14 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:Australia
gptkb:Brazil
gptkb:India
gptkb:Japan
gptkb:Mexico
gptkb:New_Zealand
gptkb:South_Africa
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:premiered_on
|
1 to 3 hours
|
|
gptkbp:products
|
Desloratadine
|
|
gptkbp:side_effect
|
fatigue
headache
drowsiness
dry mouth
|
|
gptkbp:type_of
|
79794-75-5
|